Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-047157
Filing Date
2010-03-04
Accepted
2010-03-03 21:10:35
Documents
8
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1527792
2 RATIO OF EARNINGS TO FIXED CHARGES dex121.htm EX-12.1 29359
3 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 1140
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. dex231.htm EX-23.1 1974
5 CERTIFICATION CEO PURSUANT TO RULES 13A - 14(A) AND 15D - 14(A) dex311.htm EX-31.1 10141
6 CERTIFICATION OF PFO PURSUANT TO RULES 13A - 14(A) AND 15D - 14(A) dex312.htm EX-31.2 10401
7 CERTIFICATION OF CEO AND PFO PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 6120
8 GRAPHIC g15878g54x04.jpg GRAPHIC 53186
  Complete submission text file 0001193125-10-047157.txt   1661735
Mailing Address 3180 PORTER DRIVE PALO ALTO CA 94304
Business Address 3180 PORTER DRIVE PALO ALTO CA 94304 650-496-3777
JAZZ PHARMACEUTICALS INC (Filer) CIK: 0001232524 (see all company filings)

EIN.: 050563787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33500 | Film No.: 10655336
SIC: 2834 Pharmaceutical Preparations